type here...

CATEGORIES

Mental Health

LATEST

1...111213...53Page 12 of 53

TRENDING

EDITORS CHOICE

First Drug Synthesized by AI Goes into Clinical Trials

Dr Sohail Merchant -
If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

Reduce Dementia by Staying Active

Michael Hunter, MD -
ARE YOU PHYSICALLY ACTIVE? I have some good news for you: Older adults who participate in a variety of activities appear to reduce their dementia...

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Clinic Notes: What My Patients Said This Week

Michael Hunter, MD -
Not everything I learn comes from a chart. Sometimes it’s a look. A line. A moment that lands deeper than diagnosis. This brief essay is a collection of...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories